Cloning, sequencing and expression of immunoglobulin variable regions of murine monoclonal antibodies specific for the P1.7 and P1.16 PorA protein loops of Neisseria meningitidis

Scandinavian Journal of Immunology

Volumn 57, Issue 5, 2003, Pages 453-462

  Ihle, O ^a   Beckstrom K J ^a,c   Michaelsen, T E ^a,b  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; MONOCLONAL ANTIBODY; PORIN A; PROTEIN P1.16; PROTEIN P1.7; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY SPECIFICITY; ANTIGEN BINDING; ANTIGEN EXPRESSION; ARTICLE; BACTERIAL INFECTION; CHIMERA; CONTROLLED STUDY; GENE SEQUENCE; GERM LINE; IMMUNE RESPONSE; IMMUNOGLOBULIN VARIABLE REGION; MOLECULAR CLONING; MOUSE; NEISSERIA MENINGITIDIS; NONHUMAN; NUCLEOTIDE SEQUENCE; OPSONIZATION; OUTER MEMBRANE; PRIORITY JOURNAL; VACCINATION; X RAY CRYSTALLOGRAPHY;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODIES, MONOCLONAL; ANTIGEN-ANTIBODY REACTIONS; ANTIGENS, BACTERIAL; BASE SEQUENCE; CLONING, MOLECULAR; EPITOPES, B-LYMPHOCYTE; GENES, IMMUNOGLOBULIN; HUMANS; IMMUNOGLOBULIN CONSTANT REGIONS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN VARIABLE REGION; MICE; MOLECULAR SEQUENCE DATA; NEISSERIA MENINGITIDIS; PEPTIDE FRAGMENTS; PORINS; RECOMBINANT FUSION PROTEINS; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY;

EID: 0038292003     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.2003.01255.x     Document Type: Article

References (27)

1. van der Voort ER, van Dijken H, van der Kuipers B et al. Human B-and T-cell responses after immunization with a hexavalent PorA meningococcal outer membrane vesicle vaccine. Infect Immun 1997;65:5184-90.
2. Guttormsen HK, Wetzler LM, Solberg CO. Humoral immune response to class 1 outer membrane protein during the course of meningococcal disease. Infect Immun 1994;62:1437-43.
3. van der LP, Heckels JE, Virji M, Hoogerhout P, Poolman JT. Topology of outer membrane porins in pathogenic Neisseria spp. Infect Immun 1991;59:2963-71.
4. Aase A, Hoiby EA, Michaelsen TE. Opsonophagocytic and bactericidal activity mediated by purified IgG subclass antibodies after vaccination with the Norwegian group B meningococcal vaccine. Scand J Immunol 1998;47:388-96.
5. Lehmann AK, Halstensen A, Aaberge IS et al. Human opsonins induced during meningococcal disease recognize outer membrane proteins PorA and PorB. Infect Immun 1999;67:2552-60.
6. Naess LM, Aarvak T, Aase A et al. Human IgG subclass responses in relation to serum bactericidal and opsonic activities after immunization with three doses of the Norwegian serogroup B meningococcal outer membrane vesicle vaccine. Vaccine 1999;17:754-64.
7. Wang J, Jarvis GA, Achtman M et al. Functional activities and immunoglobulin variable regions of human and murine monoclonal antibodies specific for the P1.7 PorA protein loop of Neisseria meningitidis. Infect Immun 2000;68:1871-8.
8. van den Elsen JM, Herron JN, Hoogerhout P et al. Bactericidal antibody recognition of a PorA epitope of Neisseria meningitidis. crystal structure of a Fab fragment in complex with a fluorescein-conjugated peptide. Proteins 1997;29:113-25.
9. Vidarsson G, Der Pol WL, van den Elsen JM et al. Activity of human IgG and IgA subclasses in immune defense against Neisseria meningitidis serogroup B. J Immunol 2001;166:6250-6.
10. Norderhaug L, Olafsen T, Michaelsen TE, Sandlie I. Versatile vectors for transient and stable expression of recombinant antibody molecules in mammalian cells. J Immunol Methods 1997;204:77-7.
11. Michaelsen TE, Aase A, Kolberg J, Wedge E, Rosenqvist E. PorB3 outer membrane protein on Neisseria meningitidis is poorly accessible for antibody binding on live bacteria. Vaccine 2001;19:1526-33.
12. Delvig AA, Wedege E, Caugant DA et al. A linear B-cell epitope on the class 3 outer-membrane protein of Neisseria meningitidis recognized after vaccination with the Norwegian group B outer-membrane vesicle vaccine. Microbiology 1995;141:1593-600.
13. Wedege E, Bryn K, Froholm LO. Restoration of antibody binding to blotted meningococcal outer membrane proteins using various detergents. J Immunol Methods 1988;113:51-9.
14. Ihle O, Michaelsen TE. Efficient purification of DNA fragments using a protein binding membrane. Nucleic Acids Res 2000;28:E76.
15. Kabat EA. Sequences of Proteins of Immunological Interest. Bethesda, MD: U.S. Department of Health and Human Services, Public. Health Service, National Institutes of Health, 1991.
16. Chothia C, Lesk AM, Tramontano A et al. Conformations of immunoglobulin hypervariable regions. Nature 1989;342:877-83.
17. Brodeur PH, Osman GE, Mackle JJ, Lalor TM. The organization of the mouse Igh-V locus. Dispersion, interspersion, and the evolution of VH gene family clusters. J Exp Med 1988;168:2261-78.
18. Yancopoulos GD, Desiderio SV, Paskind M, Kearney JF, Baltimore D, Alt FW. Preferential utilization of the most JH-proximal VH gene segments in pre-B-cell lines. Nature 1984;311:727-33.
19. Haines BB, Angeles CV, Parmelee AP, McLean PA, Brodeur PH. Germline diversity of the expressed BALB/c VhJ558 gene family. Mol Immunol 2001;38:9-18.
20. Corbet S, Milili M, Fougereau M, Schiff C. Two V kappa germ-line genes related to the GAT idiotypic network (Ab1 and Ab3/Ab1′) account for the major subfamilies of the mouse V kappa-1 variability subgroup. J Immunol 1987;138:932-9.
21. Ng KH, Lavigueur A, Ricard L et al. Characterization of allelic V kappa-1 region genes in inbred strains of mice. J Immunol 1989;143:638-48.
22. Alt FW, Rosenberg N, Enea V, Siden E, Baltimore D. Multiple immunoglobulin heavy-chain gene transcripts in Abelson murine leukemia virus-transformed lymphoid cell lines. Mol Cell Biol 1982;2:386-400.
23. van den Brink EN, Bril WS, Turenhout EA et al. Two classes of germline genes both derived from the V(H)1 family direct the formation of human antibodies that recognize distinct antigenic sites in the C2 domain of factor VIII. Blood 2002;99:2828-34.
24. Wedege E, Hoiby EA, Rosenqvist E, Bjune G. Immune responses against major outer membrane antigens of Neisseria meningitidis in vaccines and controls who contracted meningococcal disease during the Norwegian serogroup B protection trial. Infect Immun 1998;66:3223-31.
25. Idanpaan-Heikkila I, Hoiby EA, Chattopadhyay P, Airaksinen U, Michaelsen TM, Wedege E. Antibodies to meningococcal class 1 outer-membrane protein and its variable regions in patients with systemic meningococcal disease. J Med Microbiol 1995;43: 335-43.
26. Rosenqvist E, Hoiby EA, Wedege E et al. Human antibody responses to meningococcal outer membrane antigens after three doses of the Norwegian group B meningococcal vaccine. Infect Immun 1995;63:4642-52.
27. Wedege E, Bjune G, Froholm LO, Hoiby EA, Rosenqvist E. Immunoblotting studies of vaccine and patient sera from a Norwegian serogroup B meningococcal vaccination trial. NIPH Ann 1991;14:183-4.